✦ LIBER ✦

Randomized phase III trial of radiation treatment ± amifostine in patients with advanced-stage lung cancer

✍ Scribed by Dosia Antonadou; Nikos Coliarakis; Maria Synodinou; Helen Athanassiou; Athina Kouveli; Cosmas Verigos; Grigoris Georgakopoulos; Katerina Panoussaki; Pantelis Karageorgis; Nicolas Throuvalas

Book ID: 108434397
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 136 KB
Volume: 51
Category: Article
ISSN: 0360-3016
DOI: 10.1016/s0360-3016(01)01713-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase III randomized double blind placeb

Phase III randomized double blind placebo controlled trial of carboplatin and radiation therapy ± amifostine in patients with head and neck cancer

✍ J. Buentzel; A. Monnier; J. Ammon; G. Schmitt; N. Willich; L. Hammershaimb; G. A 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 20 KB

A randomized phase II trial of amonafide

A randomized phase II trial of amonafide or trimetrexate in patients with advanced non-small cell lung cancer. A trial of the north central cancer treatment group

✍ Dean H. Gesme Jr.; James R. Jett; Dennis D. Schreffler; John Q. Su; James A. Mai 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 376 KB 👁 2 views

Phase III randomized trial of sunitinib

Phase III randomized trial of sunitinib versus capecitabine in patients with previously treated HER2-negative advanced breast cancer

✍ Carlos H. Barrios; Mei-Ching Liu; Soo Chin Lee; Laurence Vanlemmens; Jean-Marc F 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 289 KB

A randomized phase III trial of adjuvant

A randomized phase III trial of adjuvant treatment for resected non-small cell lung cancer in Japan

✍ Yukito Ichinose 📂 Article 📅 2006 🏛 Springer 🌐 English ⚖ 294 KB

Phase II trial of chloroquinoxaline sulf

Phase II trial of chloroquinoxaline sulfonamide (CQS) in patients with stage III and IV non-small-cell lung cancer

✍ Vincent A. Miller; James R. Rigas; William P. Tong; Janice R. Reid; Katherine M. 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 129 KB

Phase 1 trial of everolimus and gefitini

Phase 1 trial of everolimus and gefitinib in patients with advanced nonsmall-cell lung cancer

✍ Daniel T. Milton; Gregory J. Riely; Christopher G. Azzoli; Jorge E. Gomez; Rober 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 123 KB 👁 3 views

## Abstract ## BACKGROUND. Preclinical studies have demonstrated that the inhibition of the PI3K/Akt/mTOR pathway restores gefitinib sensitivity in resistant cancer cell lines. A phase 1 study was conducted of the combination of everolimus, an mTOR inhibitor, and gefitinib to determine a daily dos